| Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies I Ferrer, T Gomez-Isla, B Puig, M Freixes, E Ribe, E Dalfo, J Avila Current Alzheimer Research 2 (1), 3-18, 2005 | 384 | 2005 |
| Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis EV Ilieva, V Ayala, M Jové, E Dalfó, D Cacabelos, M Povedano, ... Brain 130 (12), 3111-3123, 2007 | 376 | 2007 |
| Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation: effects of Alzheimer disease and identification of lipoxidation targets R Pamplona, E Dalfó, V Ayala, MJ Bellmunt, J Prat, I Ferrer, ... Journal of Biological Chemistry 280 (22), 21522-21530, 2005 | 335 | 2005 |
| Evidence of oxidative stress in the neocortex in incidental Lewy body disease E Dalfó, M Portero-Otín, V Ayala, A Martínez, R Pamplona, I Ferrer Journal of Neuropathology & Experimental Neurology 64 (9), 816-830, 2005 | 303 | 2005 |
| Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression I Ferrer, I López-González, M Carmona, L Arregui, E Dalfó, ... Journal of Neuropathology & Experimental Neurology 73 (1), 81-97, 2014 | 227 | 2014 |
| Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease I Ferrer, A Martinez, R Blanco, E Dalfó, M Carmona Journal of neural transmission 118, 821-839, 2011 | 216 | 2011 |
| Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons J Pujols, S Peña-Díaz, DF Lázaro, F Peccati, F Pinheiro, D González, ... Proceedings of the National Academy of Sciences 115 (41), 10481-10486, 2018 | 196 | 2018 |
| Caspase‐dependent and caspase‐independent signalling of apoptosis in the penumbra following middle cerebral artery occlusion in the adult rat I Ferrer, B Friguls, E Dalfo, C Justicia, AM Planas Neuropathology and applied neurobiology 29 (5), 472-481, 2003 | 183 | 2003 |
| Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies G Muntane, E Dalfo, A Martinez, I Ferrer Neuroscience 152 (4), 913-923, 2008 | 166 | 2008 |
| Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following … I Ferrer, B Friguls, E Dalfó, AM Planas Acta neuropathologica 105, 425-437, 2003 | 161 | 2003 |
| Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of … JL Albasanz, E Dalfó, I Ferrer, M Martín Neurobiology of disease 20 (3), 685-693, 2005 | 135 | 2005 |
| Increased sensitivity to MPTP in human α-synuclein A30P transgenic mice M Nieto, FJ Gil-Bea, E Dalfó, M Cuadrado, F Cabodevilla, B Sánchez, ... Neurobiology of aging 27 (6), 848-856, 2006 | 121 | 2006 |
| Expression of stress‐activated kinases c‐Jun N‐terminal kinase (SAPK/JNK‐P) and p38 kinase (p38‐P), and tau hyperphosphorylation in neurites surrounding βA … B Puig, T Gómez‐Isla, E Ribe, M Cuadrado, B Torrejón‐Escribano, ... Neuropathology and applied neurobiology 30 (5), 491-502, 2004 | 118 | 2004 |
| Abnormal α-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease E Dalfo, M Barrachina, JL Rosa, S Ambrosio, I Ferrer Neurobiology of disease 16 (1), 92-97, 2004 | 114 | 2004 |
| Abnormal α-synuclein interactions with Rab proteins in α-synuclein A30P transgenic mice E Dalfo, T Gómez-Isla, JL Rosa, MN Bodelón, MC Tejedor, M Barrachina, ... Journal of Neuropathology & Experimental Neurology 63 (4), 302-313, 2004 | 114 | 2004 |
| Neurochemistry and the non-motor aspects of PD I Ferrer, I López-Gonzalez, M Carmona, E Dalfó, A Pujol, A Martínez Neurobiology of disease 46 (3), 508-526, 2012 | 113 | 2012 |
| Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease I Ferrer, E Perez, E Dalfó, M Barrachina Neuroscience letters 415 (3), 205-209, 2007 | 97 | 2007 |
| Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt–Jakob disease M Freixes, A Rodriguez, E Dalfo, I Ferrer Neurobiology of aging 27 (12), 1807-1815, 2006 | 96 | 2006 |
| Early α-synuclein lipoxidation in neocortex in Lewy body diseases E Dalfó, I Ferrer Neurobiology of Aging 29 (3), 408-417, 2008 | 80 | 2008 |
| Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies M Barrachina, E Castaño, E Dalfó, T Maes, C Buesa, I Ferrer Neurobiology of disease 22 (2), 265-273, 2006 | 80 | 2006 |
Manuel Portero-OtinIRBLleida UdLDirección de correo verificada de mex.udl.cat
